O. O. Isik Et Al. , "HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS," European Congress of Rheumatology (EULAR) , Milan, Italy, pp.1187, 2023
Isik, O. O. Et Al. 2023. HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS. European Congress of Rheumatology (EULAR) , (Milan, Italy), 1187.
Isik, O. O., Basaran, E., TEMİZ KARADAĞ, D., Yazici, A., & Cefle, A., (2023). HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS . European Congress of Rheumatology (EULAR) (pp.1187). Milan, Italy
Isik, O. Et Al. "HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS," European Congress of Rheumatology (EULAR), Milan, Italy, 2023
Isik, O. O. Et Al. "HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS." European Congress of Rheumatology (EULAR) , Milan, Italy, pp.1187, 2023
Isik, O. O. Et Al. (2023) . "HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS." European Congress of Rheumatology (EULAR) , Milan, Italy, p.1187.
@conferencepaper{conferencepaper, author={O. Ozdemir Isik Et Al. }, title={HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS}, congress name={European Congress of Rheumatology (EULAR)}, city={Milan}, country={Italy}, year={2023}, pages={1187} }